CBT CABOT CORP
Miscellaneous Chemical Products · NYSE · SEC CIK 16040 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-4.7%
TTM net income YoY-55.3%
TTM EPS YoY-53.3%
Revenue 3-yr CAGR-3.8%
Net income 3-yr CAGR-14.6%
Margins
Gross margin22.7%
Operating margin13.6%
Net margin5.2%
FCF margin7.7%
EBITDA margin18.5%
Returns
ROE12.1%
ROA4.9%
ROIC (approx.)10.9%
Asset turnover0.93x
Leverage & solvency
Liabilities / assets56.4%
Debt / equity0.68x
Current ratio1.47x
Interest coverage6.66x
Cash quality & payout
Operating cash flow / net income2.62x
Accruals ratio-7.9%
Payout ratio51.1%
Capex / revenue5.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-06-30 | 2026Q22026-03-31 | 2026Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $982.00M | $904.00M | $849.00M | $899.00M | $923.00M | $936.00M | $955.00M | $1.00B |
| Cost of revenue | $798.00M | $694.00M | $638.00M | $679.00M | $679.00M | $695.00M | $720.00M | $761.00M |
| Gross profit | $184.00M | $210.00M | $211.00M | $220.00M | $244.00M | $241.00M | $235.00M | $240.00M |
| R&D expense | $13.00M | $14.00M | $13.00M | $15.00M | $15.00M | $15.00M | $14.00M | $17.00M |
| SG&A expense | $73.00M | $67.00M | $69.00M | $68.00M | $62.00M | $64.00M | $66.00M | $73.00M |
| Operating income | $98.00M | $129.00M | $129.00M | $137.00M | $167.00M | $162.00M | $155.00M | $150.00M |
| Interest expense | $18.00M | $18.00M | $18.00M | $20.00M | $19.00M | $19.00M | $18.00M | $19.00M |
| Pretax income | $58.00M | $120.00M | $118.00M | $115.00M | $155.00M | $151.00M | $144.00M | $135.00M |
| Income tax | $46.00M | $44.00M | $37.00M | $63.00M | $43.00M | $49.00M | $41.00M | -$10.00M |
| Net income | $6.00M | $68.00M | $73.00M | $43.00M | $101.00M | $94.00M | $93.00M | $137.00M |
| EBITDA | $148.00M | $178.00M | $170.00M | $177.00M | $206.00M | $200.00M | $192.00M | $187.00M |
| EPS (basic) | 0.12 | 1.27 | 1.38 | — | 1.87 | 1.71 | 1.69 | — |
| EPS (diluted) | 0.12 | 1.27 | 1.37 | — | 1.86 | 1.69 | 1.67 | — |
| Dividends declared per share | 0.47 | 0.45 | 0.45 | 0.45 | 0.45 | 0.43 | 0.43 | 0.43 |
| Weighted avg. shares (diluted) | 52.00M | 52.20M | 52.90M | — | 53.80M | 54.40M | 55.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $250.00M | $252.00M | $230.00M | $258.00M | $239.00M | $213.00M | $183.00M | $223.00M |
| Inventory | $566.00M | $522.00M | $503.00M | $504.00M | $531.00M | $541.00M | $536.00M | $552.00M |
| Current assets | $1.67B | $1.55B | $1.46B | $1.54B | $1.57B | $1.60B | $1.50B | $1.60B |
| PP&E, net | $1.74B | $1.75B | $1.73B | $1.71B | $1.67B | $1.60B | $1.56B | $1.53B |
| Goodwill | $137.00M | $136.00M | $136.00M | $134.00M | $133.00M | $128.00M | $127.00M | $133.00M |
| Intangibles | $52.00M | $53.00M | $54.00M | $55.00M | $56.00M | $55.00M | $57.00M | $53.00M |
| Total assets | $3.98B | $3.90B | $3.76B | $3.81B | $3.84B | $3.78B | $3.64B | $3.74B |
| Current liabilities | $1.14B | $1.07B | $874.00M | $957.00M | $740.00M | $818.00M | $747.00M | $772.00M |
| Short-term debt | $261.00M | $261.00M | $260.00M | $260.00M | $10.00M | $9.00M | $9.00M | $8.00M |
| Long-term debt | $828.00M | $863.00M | $854.00M | $856.00M | $1.10B | $1.09B | $1.09B | $1.09B |
| Total debt | $1.09B | $1.12B | $1.11B | $1.12B | $1.11B | $1.10B | $1.10B | $1.09B |
| Total liabilities | $2.24B | $2.21B | $2.03B | $2.11B | $2.15B | $2.19B | $2.13B | $2.15B |
| Shareholders' equity | $1.60B | $1.57B | $1.57B | $1.55B | $1.54B | $1.43B | $1.37B | $1.43B |
| Net debt | $839.00M | $872.00M | $884.00M | $858.00M | $876.00M | $886.00M | $915.00M | $872.00M |
| Shares outstanding | 51.63M | 51.58M | 52.22M | 52.84M | 53.20M | 53.70M | 54.22M | 54.30M |
| Cash flow statement | ||||||||
| Operating cash flow | $75.00M | $77.00M | $126.00M | $219.00M | $249.00M | $73.00M | $124.00M | $204.00M |
| Capital expenditure | $38.00M | $45.00M | $69.00M | $64.00M | $61.00M | $72.00M | $77.00M | $92.00M |
| Free cash flow | $37.00M | $32.00M | $57.00M | $155.00M | $188.00M | $1.00M | $47.00M | $112.00M |
| Investing cash flow | -$38.00M | -$109.00M | -$69.00M | -$59.00M | -$65.00M | -$70.00M | -$104.00M | -$89.00M |
| Financing cash flow | -$49.00M | $53.00M | -$92.00M | -$146.00M | -$183.00M | $17.00M | -$24.00M | -$89.00M |
| Depreciation & amortization | $50.00M | $49.00M | $41.00M | $40.00M | $39.00M | $38.00M | $37.00M | $37.00M |
| Stock-based compensation | $6.00M | $4.00M | $3.00M | $5.00M | $5.00M | $6.00M | $8.00M | $6.00M |
| Dividends paid | $24.00M | $24.00M | $24.00M | $25.00M | $24.00M | $23.00M | $24.00M | $24.00M |
| Share buybacks | $0 | $49.00M | $52.00M | $39.00M | $40.00M | $47.00M | $42.00M | $66.00M |
Free plan shows the latest 8 periods; Pro shows all 69 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.